Lifevantage Q4 2024 Adj. EPS $0.14 Misses $0.21 Estimate, Sales $48.931M Miss $50.952M Estimate
Portfolio Pulse from Benzinga Newsdesk
Lifevantage reported Q4 2024 earnings per share of $0.14, missing the analyst estimate of $0.21. Sales were $48.931 million, below the expected $50.952 million, and down 9.76% from the previous year.
August 28, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Lifevantage's Q4 2024 earnings and sales both missed analyst estimates, with EPS at $0.14 versus $0.21 expected and sales at $48.931 million versus $50.952 million expected. This represents a 9.76% decrease in sales from the previous year.
The earnings per share and sales figures both missed analyst expectations, which is likely to negatively impact the stock price in the short term. The decrease in sales compared to the previous year further adds to the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100